AKT1 and cancer: IL-17β seems to induce metastasis and tumorigenicity by overexpression of EMT markers and activation of AKT/GSK3-β/β-catenin pathways in cancer cells, resulting in expression of stemness markers such as Oct4, Sox2 and Nanog (Fig. 3) [70].